Ganga Pharmaceuticals Ltd — Others, 26-08-2025: AGM/EGM

Ganga Pharmaceuticals Limited will hold its 36th Annual General Meeting to approve the financial statements for the year ended March 31, 2025. Shareholders will also vote on re-appointing Mrs. Srijna Sharma as a Director. Additionally, the meeting includes proposals for appointing Mr. Munna Baijnath Chaurasia and Mr. Aman Mukesh Chaudhari as Independent Directors for five-year terms, effective from March 27, 2025. These appointments, initially made by the Board, are now subject to shareholder approval, strengthening the board's independent oversight.